All times are listed in CEST (Central European Summer Time)

Browsing Over 54 Sessions

Sort By
View
Multidisciplinary Interactive session Congress Hall Congress Hall

Oligoprogression in Advanced NSCLC (ID 7)

Date
Thu, 31.03.2022
Time
08:00 - 09:00
Chairs
  • Fiona McDonald, London, GB
Location
Congress Hall
Controversy session Forum Hall Forum Hall

Surgery vs radiation therapy for stage III NSCLC in the context of immunotherapy (ID 8)

Date
Thu, 31.03.2022
Time
08:00 - 09:00
Chairs
  • Kersti Oselin, Tallinn, EE
Location
Forum Hall
Special Symposium Forum Hall Forum Hall

Minimal residual disease, biological disease (ID 9)

Date
Thu, 31.03.2022
Time
09:15 - 10:45
Chairs
  • Christopher Z. Abbosh, London, GB
Location
Forum Hall
ESMO Colloquium Congress Hall Congress Hall

ESMO Colloquium supported by Eli Lilly and company - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR (ID 36)

Date
Thu, 31.03.2022
Time
09:15 - 10:45
Location
Congress Hall
Educational session South Hall 2 South Hall 2

Telemedicine in lung cancer: What to do in 2022? (ID 10)

Date
Thu, 31.03.2022
Time
09:15 - 10:45
Chairs
  • Natasha Leighl, Toronto, CA
Location
South Hall 2
Multidisciplinary Tumour Board Congress Hall Congress Hall

Personalized treatment of lung cancer brain metastases (ID 11)

Date
Thu, 31.03.2022
Time
11:15 - 12:45
Chairs
  • Jordi Remon Masip, Barcelona, ES
  • Lizza Hendriks, Maastricht, NL
Location
Congress Hall
Educational session Forum Hall Forum Hall

First line in non-oncogene addicted NSCLC (ID 12)

Date
Thu, 31.03.2022
Time
11:15 - 12:45
Chairs
  • Josephine Feliciano, Baltimore, US
Location
Forum Hall
Multidisciplinary Tumour Board South Hall 2 South Hall 2

More targets, more drugs, more choices, more conflicts  (ID 13)

Date
Thu, 31.03.2022
Time
11:15 - 12:45
Chairs
  • Keith M. Kerr, Aberdeen, GB
Location
South Hall 2
Forum Hall Thu, 31.03.2022 13:30 - 15:00

Janssen Oncology - Evolving treatment options and practices in EGFR-mutant NSCLC (ID 37)

Time
13:30 - 15:00
Location
Forum Hall
Date
Thu, 31.03.2022
South Hall 2 Thu, 31.03.2022 13:30 - 15:00

AstraZeneca - CNS disease management in EGFRm NSCLC (ID 38)

Time
13:30 - 15:00
Location
South Hall 2
Date
Thu, 31.03.2022
Proffered Paper session Congress Hall Congress Hall

Proffered Paper session 2 (ID 44)

Date
Thu, 31.03.2022
Time
15:10 - 16:40
Location
Congress Hall
Mini Oral session South Hall 2 South Hall 2

Mini Oral session 1 (ID 45)

Date
Thu, 31.03.2022
Time
17:00 - 18:00
Location
South Hall 2